EQUITY RESIDENTIAL ($EQR) posted quarterly earnings results on Tuesday, October 28th. The company reported earnings of $1.02 per share, beating estimates of $0.44 by $0.58. The company also reported revenue of $782,410,000, missing estimates of $788,729,028 by $-6,319,028.
You can see Quiver Quantitative's $EQR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EQUITY RESIDENTIAL Insider Trading Activity
EQUITY RESIDENTIAL insiders have traded $EQR stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EQR stock by insiders over the last 6 months:
- CATHERINE CARRAWAY (EVP & CHRO) sold 1,007 shares for an estimated $71,043
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EQUITY RESIDENTIAL Hedge Fund Activity
We have seen 345 institutional investors add shares of EQUITY RESIDENTIAL stock to their portfolio, and 309 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,235,042 shares (-90.2%) from their portfolio in Q2 2025, for an estimated $285,822,984
- DEUTSCHE BANK AG\ added 3,184,130 shares (+256.3%) to their portfolio in Q2 2025, for an estimated $214,896,933
- CITADEL ADVISORS LLC removed 1,392,088 shares (-72.4%) from their portfolio in Q2 2025, for an estimated $93,952,019
- INVESCO LTD. added 1,384,580 shares (+20.9%) to their portfolio in Q2 2025, for an estimated $93,445,304
- JPMORGAN CHASE & CO removed 1,317,296 shares (-28.9%) from their portfolio in Q2 2025, for an estimated $88,904,307
- GRS ADVISORS, LLC added 1,045,798 shares (+inf%) to their portfolio in Q2 2025, for an estimated $70,580,907
- MACQUARIE GROUP LTD removed 983,004 shares (-24.9%) from their portfolio in Q2 2025, for an estimated $66,342,939
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EQUITY RESIDENTIAL Congressional Stock Trading
Members of Congress have traded $EQR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EQR stock by members of Congress over the last 6 months:
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
EQUITY RESIDENTIAL Analyst Ratings
Wall Street analysts have issued reports on $EQR in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 10/13/2025
- Barclays issued a "Overweight" rating on 09/30/2025
- Truist Securities issued a "Buy" rating on 08/29/2025
- Stifel issued a "Buy" rating on 08/05/2025
- UBS issued a "Buy" rating on 07/15/2025
To track analyst ratings and price targets for EQUITY RESIDENTIAL, check out Quiver Quantitative's $EQR forecast page.
EQUITY RESIDENTIAL Price Targets
Multiple analysts have issued price targets for $EQR recently. We have seen 10 analysts offer price targets for $EQR in the last 6 months, with a median target of $75.0.
Here are some recent targets:
- Steve Sakwa from Evercore ISI Group set a target price of $71.0 on 10/13/2025
- Richard Anderson from Cantor Fitzgerald set a target price of $70.0 on 10/01/2025
- Richard Hightower from Barclays set a target price of $80.0 on 09/30/2025
- Michael Lewis from Truist Securities set a target price of $75.0 on 08/29/2025
- James Feldman from Wells Fargo set a target price of $68.0 on 08/27/2025
- Nicholas Yulico from Scotiabank set a target price of $77.0 on 08/14/2025
- Adam Kramer from Morgan Stanley set a target price of $75.0 on 08/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.